What the New HHS-Wide Nine-Application Cap Means for SBIR/STTR Companies
HHS will limit SBIR/STTR applicants to nine proposals annually, forcing companies to rethink submission volume and funding strategy.
HHS will limit SBIR/STTR applicants to nine proposals annually, forcing companies to rethink submission volume and funding strategy.
HHS applicants are now encouraged to consider the MAHA Strategy. The language is optional, but the signal may not be.
Montana Innovation Partnership offers $2,000 FAST Microgrants for SBIR/STTR prep—only six awarded each year, so apply early.
Certain NIH and FDA components no longer accept clinical trials through Parent NOFOs, creating major application screening risks.
HHS Parent NOFOs now use a clinical trial optional structure, simplifying application selection while changing proposal strategy.
LaunchTN offers $6,000 to support SBIR proposals and commercialization efforts for early-stage tech companies that meet training and match criteria.
NIH budget limits vary significantly by Institute, creating funding opportunities ranging from Phase I awards to $15 million Phase IIBs.
NIH SBIR/STTR funding is back, but applicants should pay close attention to new structures, requirements, and emerging signals.
North Carolina offers up to $12,000 in reimbursement for SBIR/STTR proposal development through the One NC Small Business Program.
Cornell’s SBIR/STTR Assistance Program helps New York innovators adapt to new reauthorization changes and submit stronger, more competitive proposals.